|
1
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vodenkova S, Buchler T, Cervena K,
Veskrnova V, Vodicka P and Vymetalkova V: 5-fluorouracil and other
fluoropyrimidines in colorectal cancer: Past, present and future.
Pharmacol Ther. 206:1074472020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou DD, Liu XF, Lu CW, Pant OP and Liu
XD: Long non-coding RNA PVT1: Emerging biomarker in digestive
system cancer. Cell Prolif. 50:e123982017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cory S, Graham M, Webb E, Corcoran L and
Adams JM: Variant (6;15) translocations in murine plasmacytomas
involve a chromosome 15 locus at least 72 kb from the c-myc
oncogene. EMBO J. 4:675–681. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng X, Hu H and Li S: High expression of
lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal
transition in esophageal cancer. Oncol Lett. 12:2357–2362. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang XW, Bu P, Liu L, Zhang XZ and Li J:
Overexpression of long non-coding RNA PVT1 in gastric cancer cells
promotes the development of multidrug resistance. Biochem Biophys
Res Commun. 462:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X,
Zhang X, Huang Y, Zhang R, Wei J, et al: LncRNA PVT1 promotes
gemcitabine resistance of pancreatic cancer via activating
Wnt/β-catenin and autophagy pathway through modulating the
miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 19:1182020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du P, Hu C, Qin Y, Zhao J, Patel R, Fu Y,
Zhu M, Zhang W and Huang G: LncRNA PVT1 mediates antiapoptosis and
5-fluorouracil resistance via increasing Bcl2 expression in gastric
cancer. J Oncol. 2019:93254072019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan H, Zhu JH and Yao XQ: Knockdown of
long noncoding RNA PVT1 reverses multidrug resistance in colorectal
cancer cells. Mol Med Rep. 17:8309–8315. 2018.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xian Z, Hu B, Wang T, Zeng J, Cai J, Zou Q
and Zhu P: lncRNA UCA1 contributes to 5-fluorouracil resistance of
colorectal cancer cells through miR-23b-3p/ZNF281 axis. Onco
Targets Ther. 13:7571–7583. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng J, Lei W, Fu JC, Zhang L, Li JH and
Xiong JP: Targeting miR-21 enhances the sensitivity of human colon
cancer HT-29 cells to chemoradiotherapy in vitro. Biochem Biophys
Res Commun. 443:789–795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kartha RV and Subramanian S: Competing
endogenous RNAs (ceRNAs): New entrants to the intricacies of gene
regulation. Front Genet. 5:82014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Fu J, Zhang Z and Qin H:
miR-486-5p regulates the migration and invasion of colorectal
cancer cells through targeting PIK3R1. Oncol Lett. 15:7243–7248.
2018.PubMed/NCBI
|
|
20
|
Liu Z, Gu Y, Cheng X, Jiang H, Huang Y,
Zhang Y, Yu G, Cheng Y and Zhou L: Upregulation lnc-NEAT1
contributes to colorectal cancer progression through sponging
miR-486-5p and activating NR4A1/Wnt/beta-catenin pathway. Cancer
Biomark. 30:309–319. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao X, Leone GW and Wang H: Cyclin
D-CDK4/6 functions in cancer. Adv Cancer Res. 148:147–169. 2020.
View Article : Google Scholar : PubMed/NCBI
|
